NCT05507957

Brief Summary

Sepsis accounts for high morbidity and mortality rates in ICU globally. Early recognition of sepsis with appropriate antimicrobial therapy is critical for the appropriate management of patients (1). Blood culture (BC) is considered the gold standard for sepsis etiological diagnosis , with good sensitivity ,but suffering usually of delay or even failure to detect microorganisms in patients already treated with antimicrobials and failure to identify pathogens other than bacteria or yeast (2, 3). Time-to-positivity (TTP) of blood cultures is defined as the time from the start of incubation to a positive signal. Knowledge of the distribution of blood culture TTP is of clinical benefit in the re-evaluation of patients with a clinical syndrome consistent with infection. A low probability of bacteremia when blood cultures have remained negative after 24 hours (4). Positive episodes with TTP more than or equal 24 h are commonly optimally treated infections, catheter-related infections, or infections caused by slowly growing microorganisms such as Candida or anaerobic Gram-negative bacteria. Growth of multidrug-resistant Gram-negative bacilli is exceptional beyond 24 h. In current clinical practice, bacteremia is considered unlikely if blood cultures have been negative for 48-72 hours (5, 6). Most blood culture bottles turn positive in less than 4 days, shortening the duration of incubation appears the most relevant solution in order to free additional capacity(4). Various disinfectants, such as povidone iodine (PVI), alcohol preparations, and chlorhexidine gluconate ethanol (CHG-ALC), are used for disinfection prior to blood culture sampling. Contamination rates of cultured blood samples vary according to the disinfectant used, sampling site, definition of contamination, and skill level of individuals performing the venipuncture.(7, 8) In this study, Investigators assessed the real life clinical impact on septic ICU patients based on time of blood culture positivity time.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 19, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

August 24, 2022

Status Verified

August 1, 2022

Enrollment Period

2 years

First QC Date

August 16, 2022

Last Update Submit

August 22, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Evaluate the impact of blood culture positivity time in patient management and reduction of ICU stay, as well as decreases in 30-days mortality.

    investigators measured the time to positivity of blood culture in hours. Then direct reporting the result to the physician ( as few true bloodstream infections were detected after 48 hours) ,,, Then study the impact of the result on therapeutic decisions (start of treatment, or switch or association of antibiotic/antifungal therapy). Then days of hospital stay were measured in the day unit\& mortality rate was measured in percentage

    through study completion, an average of 1 year.

  • Investigates the probability of blood culture positivity after 24 hours.

    time of positivity of blood culture measured in hours. It was calculated as the time from the start of incubation to a positive signal

    through study completion, an average of 1 year.

  • evaluate if there was diagnostic value of TTP

    see if there was a relationship between time of positivity of blood culture (in hour unit) and the type of microorganism,, and And if TTP can distinguish between contaminant and true pathogen

    through study completion, an average of 1 year.

  • Identify if there is difference in the blood culture contamination rate between uses of various type of antiseptic.

    Identify if there is a difference in the blood culture contamination rate (measured in percentage) between uses of various types of antiseptic.

    through study completion, an average of 1 year.

Secondary Outcomes (1)

  • - Identify if TTP in real life was superior to expensive modern microbiological techniques for the diagnosis of sepsis

    through study completion, an average of 1 year.

Interventions

-Disinfection using povidone-iodine, alcohol preparation or chlorhexidine gluconate ethanol (CHG-ALC ), so that each type was used on 40 patients

Also known as: use different type of disinfectants (povidone iodine (PVI), alcohol preparations, and chlorhexidine gluconate ethanol (CHG-ALC)

Eligibility Criteria

Age1 Day - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

The population of our study were patients in ICU unit in pediatric hospital of Assuit University Hospitals, that presented with clinical symptoms which may lead to a suspicion of a bloodstream infection or sepsis which is: * Undetermined fever ( ≥ 38°C) or hypothermia ( ≤ 36°C). * Shock, chills, rigors * Severe local infections (meningitis, endocarditis, pneumonia, pyelonephritis, intra-abdominal suppuration etc.)

You may qualify if:

  • The population of our study were patients in ICU unit in pediatric hospital of Assuit University Hospitals, that presented with clinical symptoms which may lead to a suspicion of a bloodstream infection or sepsis which is:
  • Undetermined fever ( ≥ 38°C) or hypothermia ( ≤ 36°C).
  • Shock, chills, rigors
  • Severe local infections (meningitis, endocarditis, pneumonia, pyelonephritis, intra-abdominal suppuration etc.) Multiple episodes of bacteremia per patient were allowed if the antimicrobial therapy for the previous episode had been completed and clinical and microbiological cure had been achieved

You may not qualify if:

  • blood culture bottles that were drawn in vacation days (because of no distinct control on transportation time, which affect TTP)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assuit university

Asyut, 71511, Egypt

Location

Related Publications (1)

  • endnote

    RESULT

Related Links

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • mohammed Z Abo krisha, professor

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

fatma s elnaggar, master

CONTACT

amal m hosni, doctora

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
master of clincical patholofy

Study Record Dates

First Submitted

August 16, 2022

First Posted

August 19, 2022

Study Start

January 1, 2023

Primary Completion

January 1, 2025

Study Completion

March 1, 2025

Last Updated

August 24, 2022

Record last verified: 2022-08

Locations